Mark is responsible for the Sales and Marketing teams for API, formulation development and finished dose at Aesica. He has extensive international experience in setting strategy and execution, and over 20 years of commercial experience, which included senior business leadership roles with contract organizations. Mark joined Aesica in early 2016 from Intertek where he was the UK Director for Chem and Pharma businesses. Mark holds a BSc in Chemistry from Anglia Ruskin University.